Pulsetto’s Global Impact: The Fastest-Growing Mental Wellness Device of 2024

February 19, 2025 at 11:18 AM EST

Surpassing $10M in revenue, Pulsetto processed nearly 40,000 orders in 2024. The company supported close to 100,000 users in managing stress and emotional well-being, earning worldwide recognition as a leader in longevity and health optimization.

Pulsetto co-founders, Povilas Sabaliauskas and Vitalijus Majorovas

Nearly half of the global population is projected to experience a mental health disorder by age 75, according to the article posted in The Lancet Psychiatry. It shows that there is an urgent need for more effective mental wellness solutions as relying on traditional medication, and even therapy hasn’t slowed the mental health pandemic. Pulsetto, a company that helps people relieve stress through their science-based vagus nerve stimulation (VNS) device introduced an innovative technological solution to battle the pandemic. Their device helps people manage stress, sleep, avoid burnout, and improve emotional well-being. The company experienced rapid growth in 2024 and has become a leader in the electronic mental wellness industry.

Pulsetto saw remarkable growth in 2024, with gross revenue hitting $10 million. This is a 3.5x increase from the previous year and a 56x growth since the company’s launch in 2021. Over the year, 39,367 orders for devices were processed through a network of more than 70 active distributors.

“We look back at how far we have come in these 3 years and are happy to see the progress,” said Vitalijus Majorovas, health tech hacker and co-founder of Pulsetto. “Many startups raise €3-4 million or more and have an advantage right from the start. We built this company with €500,000 from Kilo Health and our own resources. This was enough for us to develop Pulsetto VNS technology and be profitable from day one. As we see many positive reviews coming regularly and people telling us how our device has helped them, we understand that the med-tech industry has to continue growing.”

Pulsetto users completed over 1.3 million stress-relief sessions in 2024, which shows that the trust in the company’s VNS technology for managing mental health has been growing steadily. Most users are from the US, Canada, Australia, the UK, and Germany.

Since 2024, the device has had API integrations that allow users to monitor heart rate and heart rate variability (HRV) in real time. It offers a more personalized approach to stress management.

Athletes often face intense pressure and high stress levels, making burnout a common challenge; as a result, many are turning to technology to enhance focus, recovery, resilience, and peak performance, which led Pulsetto to partner with Paralympic silver medalist Ryan Medrano in 2024. He used company’s device to aid recovery and focus during training for the Paris Games. As a result, Pulsetto launched a subsection on their website “For Athletes”. In 2025, the company intends to start collaborating with more professional athletes to champion their devices.

Shifting focus from sports to longevity, Pulsetto gained international attention in 2024 through its feature in the Netflix documentary Don’t Die: The Man Who Wants to Live Forever. The film, featuring health optimization pioneer Bryan Johnson, positioned Pulsetto as an important tool in the longevity movement, emphasizing its role in improving quality of life and extending health spans.

“Preventive wellness practices and longevity are rapidly becoming central to health innovation,” said Povilas Sabaliauskas, stress management expert and Pulsetto co-founder. “People often turn for help after the fact, when they get hit by anxiety or have a nervous breakdown. We have to look ahead, act proactively, and use available solutions that can get faster results to recover from stress. VNS devices have already proved how advanced, drug-free solutions can address mental health challenges and support overall well-being at the same time. I believe that by helping users manage stress, improve sleep, and enhance recovery, we’re contributing to a broader shift toward proactive, sustainable health practices.”

Pulsetto is gearing up for a pivotal year in 2025, with an emphasis on advancing clinical trials and expanding its applications in wellness and beyond. The company plans a series of medical trials that have to gather concrete data on vagus nerve stimulation’s effectiveness in dealing with issues such as sleep disorders, chronic stress, and anxiety.

“We have a clear mission for 2025–to expand the boundaries of what VNS technology can achieve,” continued Majorovas.“ We’re exploring applications in areas like blood pressure regulation, inflammation, and even PTSD treatment. We hope that big data becomes more integrated into traditionally non-tech fields like medicine, and there will be more targeted and personalized approaches on how to improve wellness, speed up recovery, and stop mental health issues before they escalate.”

ABOUT PULSETTO

Pulsetto is a company that offers a scientifically based vagus nerve stimulator designed to help users manage stress by engaging the parasympathetic nervous system. With its advanced neuromodulation technology, Pulsetto provides an easy-to-use option for those looking to support mental well-being and manage stress through wearable technology.

Media Contact
Company Name: PULSETTO
Contact Person: Povilas Sabaliauskas
Email: Send Email
Country: United States
Website: https://pulsetto.tech/

About Us

Additional Information

Website & Technical Help

Pulsetto’s Global Impact: The Fastest-Growing Mental Wellness Device of 2024

More News